<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2022 17_9-10_203</article-id>
<article-id pub-id-type="doi">10.15836/ccar2022.203</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Valvular heart disease</subject></subj-group>
</article-categories>
<title-group>
<article-title>Optimal timing for surgery in infective endocarditis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5955-0275</contrib-id><name><surname>Bari&#x0107;</surname><given-names>Davor</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6245-5508</contrib-id><name><surname>&#x0160;estan</surname><given-names>Gloria</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2740-4067</contrib-id><name><surname>Uni&#x0107;</surname><given-names>Daniel</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Bla&#x017E;ekovi&#x0107;</surname><given-names>Robert</given-names></name><ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-7125-361x">https://orcid.org/0000-0001-7125-361x</ext-link></contrib>
<contrib contrib-type="author"><name><surname>Varvodi&#x0107;</surname><given-names>Josip</given-names></name><ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-6602-699x">https://orcid.org/0000-0001-6602-699x</ext-link></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5690-9924</contrib-id><name><surname>Ku&#x0161;urin</surname><given-names>Marko</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9644-9739</contrib-id><name><surname>&#x0160;u&#x0161;njar</surname><given-names>Dubravka</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4304-1852</contrib-id><name><surname>Gjorgjievska</surname><given-names>Savica</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Sli&#x0161;kovi&#x0107;</surname><given-names>Nikola</given-names></name><ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-9796-736x">https://orcid.org/0000-0002-9796-736x</ext-link></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7735-6721</contrib-id><name><surname>Rude&#x017E;</surname><given-names>Igor</given-names></name></contrib>
<aff id="aff1"><institution>University Hospital Dubrava</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Davor Bari&#x0107;, Klini&#x010D;ka bolnica Dubrava, Avenija Gojka &#x0160;u&#x0161;ka 6, HR-10000 Zagreb, Croatia. / Phone: +385-98-614-054 / E-mail: <email xlink:href="dbaric@kbd.hr">dbaric@kbd.hr</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>11</month><year>2022</year></pub-date>
<volume>17</volume>
<issue>9-10</issue>
<fpage>203</fpage>
<lpage>203</lpage>
<history>
<date date-type="received"><day>02</day><month>11</month><year>2022</year></date>
<date date-type="accepted"><day>10</day><month>11</month><year>2022</year></date>
</history>
<permissions>
<copyright-year>2022</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>infective endocarditis</kwd><kwd>cardiac surgery</kwd><kwd>surgical indications</kwd><kwd>acute</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Background</bold>: Timing of surgery continues to be one of the most challenging point of interest in management of patients with acute infective endocarditis (IE). Recent guidelines recommend early surgery in most patients as soon as indication is met. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) We present our 26-year experience of surgical treatment for IE with additional analysis of optimal timing of surgery.</p>
<p><bold>Methods and Results</bold>: An analysis of prospectively collected data of 325 adult patients who underwent surgery due to acute IE between 1996 and 2022 at our institution was performed. Isolated aortic valve IE was observed in 48%, isolated mitral valve IE in 32%, multiple valves were affected in 12% and right-sided valves involved in 7% of cases. There were 12% of patients with previous cardiac operations and 10% of patients with prosthetic valve endocarditis. Perioperative mortality was 10.7% (35/325). An additional analysis was performed on subgroup of 155 consecutive patients with supplementary data available. They were divided in 2 groups: patients operated early (up to 14 days of diagnosis) or late (after 14 days). Patients in early-surgery group were significantly younger, had better renal function, lower incidence of neurologic impairment and higher incidence of perivalvular abscess. There was an observed tendency of higher valve repair rate in late-surgery group. Difference in perioperative mortality was observed (5.3% early-surgery group; 10.0% late-surgery group) but was not significant (p=0.277).</p>
<p><bold>Conclusion</bold>: The current evidence and our experience suggests survival benefits in early operated patients with IE, if an urgent indication for early surgery is present. To delay surgery for prolongation of preoperative antibiotic therapy is likely not going to lead to any additional patient benefit.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>G</given-names></name><name><surname>Lancellotti</surname><given-names>P</given-names></name><name><surname>Antunes</surname><given-names>MJ</given-names></name><name><surname>Bongiorni</surname><given-names>MG</given-names></name><name><surname>Casalta</surname><given-names>JP</given-names></name><name><surname>Del Zotti</surname><given-names>F</given-names></name><etal/><collab>ESC Scientific Document Group</collab></person-group>. <article-title>2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).</article-title> <source>Eur Heart J</source>. <year>2015</year> November 21;<volume>36</volume>(<issue>44</issue>):<fpage>3075</fpage>&#x2013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehv319</pub-id><pub-id pub-id-type="pmid">26320109</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baddour</surname><given-names>LM</given-names></name><name><surname>Wilson</surname><given-names>WR</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names><suffix>Jr</suffix></name><name><surname>Tleyjeh</surname><given-names>IM</given-names></name><name><surname>Rybak</surname><given-names>MJ</given-names></name><etal/></person-group> <article-title>American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.</article-title> <source>Circulation</source>. <year>2015</year> October 13;<volume>132</volume>(<issue>15</issue>):<fpage>1435</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000296</pub-id><pub-id pub-id-type="pmid">26373316</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
